Bronstein, Gewirtz & Grossman, LLC Encourages New Fortress Energy Inc. (NFE) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Fortress Energy Inc. ("New Fortress" or "the Company") (NASDAQ:NFE). Investors who purchased New Fortress securities prior to December 2, 2022, and continue to hold to the present, are […]

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Methode Electronics, Inc. (MEI) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methode Electronics, Inc. ("Methode Electronics" or "the Company") (NYSE:MEI). Investors who purchased Methode Electronics securities prior to December 2, 2021, and continue to hold to the present, are encouraged to

TheLotter US Issues Warning to Unsuspecting Users: “Be Wary of Online Scams”

Online lottery courier service employs stringent security protocols TheLotter US, a trusted online lottery courier service, sends a reminder to customers to be vigilant against online phishing scams and fraudulent websites. With online lottery courier services growing in popularity, cybercriminals often target unsuspecting individuals with fraudulent emails and messages that falsely claim recipients have won

Human Organs-on-Chips Market to Reach USD 1019 Million by 2031 | 31.2% CAGR Growth Forecast – Valuates Reports

Human Organs-on-Chips Market is Segmented by Type (Brain-on-a-chip, Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip, Vessel-on-a-chip), by Application (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetics Industry). https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg The global market for Human Organs-on-Chips was valued at USD 156 Million in the year 2024 and is projected to reach a revised size of USD 1019 Million

Children’s Apparel Market is expected to generate a revenue of USD 368.34 Billion by 2031, Globally, at 4.80% CAGR: Verified Market Research®

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, “Children's Apparel Market Size and Forecast”. This comprehensive study provides valuable insights into key market trends, competitive dynamics, and future growth prospects, enabling businesses to make informed strategic decisions.

Traffic Management Market worth $75.74 billion by 2029- Exclusive Report by MarketsandMarkets™

The Traffic Management Market is expected to reach USD 75.74 billion by 2029 from USD 43.53 billion in 2024, at a CAGR of 11.7 % during 2024-2029, according to a new report by MarketsandMarkets™. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse in-depth TOC on “Traffic Management Market” 350 – Tables 60 – Figures 320 – Pages Download PDF Brochure @

United Bancorporation of Alabama, Inc. Announces Fourth Quarter Results

(OTCQX: UBAB)- United Bancorporation of Alabama, Inc. announces its financial results for the period ended December 31, 2024. United reported unaudited consolidated net income of $26.9 million or earnings per share of $7.65 for the twelve months ended December 31, 2024, as compared to net income of $31.5 million or earnings per share of $8.69

Bronstein, Gewirtz & Grossman, LLC Is Investigating XPEL, Inc. (XPEL) And Encourages Stockholders to Connect

NEW YORK, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XPEL, Inc. ("XPEL" or "the Company") (NASDAQ:XPEL). Investors who purchased XPEL securities prior to November 8, 2023, and continue to hold to the present, are encouraged to obtain additional information

Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE). Investors who purchased Sage securities prior to April 12, 2021, and continue to hold to the present, are encouraged to obtain

Scroll to Top